Table 1.
Baseline characteristics of patients.
Sanfeng Tongqiao Diwan (n = 33) | Tongqiao Biyan Pian (n = 32) | P | |
---|---|---|---|
Age (mean ± SD) | 30.39 ± 1.67 | 30.68 ± 2.08 | >0.05 |
Gender (male/female) | 19/14 | 17/15 | |
Course of the disease (mean ± SD) | 10.96 ± 1.18 | 11.96 ± 1.36 | |
Compliance (%) | 0.96 ± 0.10 | 0.97 ± 0.10 | |
Total VAS score | 17.52 ± 1.42 | 17.00 ± 1.46 | |
Total symptom relief score | 20.15 ± 0.68 | 19.4 ± 0.75 | |
Total RQLQ score | 2.42 ± 0.17 | 2.52 ± 0.16 | |
Activity limitation | 2.62 ± 0.22 | 2.85 ± 0.20 | |
Sleep problems | 1.94 ± 0.22 | 1.84 ± 0.25 | |
Nonnose/eye symptoms | 2.16 ± 0.20 | 2.09 ± 0.16 | |
Practical problems | 3.78 ± 0.24 | 3.69 ± 0.23 | |
Nose symptoms | 2.86 ± 0.22 | 3.38 ± 0.22 | |
Eye symptoms | 1.61 ± 0.21 | 1.82 ± 0.25 | |
Emotion | 1.97 ± 0.22 | 1.96 ± 0.25 | |
ESS score | 6.54 ± 0.64 | 5.66 ± 0.59 |
P value was a bilateral significance test, and P < 0.05 was considered statistically significant.